Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : TGL WHAAAAAAAT! Alerts, thoughts, discussion. -- Ignore unavailable to you. Want to Upgrade?

To: Jim Bishop who wrote (64563)	9/22/2000 12:43:07 PM
From: rogelaw	Respond to of 150070

GDSA UHA NOW I THINK I AM WITH YA THERE Bid(Size) Ask(Size) Volume 0.04(50) 0.04(50) 230,500

To: Jim Bishop who wrote (64563)	9/22/2000 12:56:51 PM
From: Joe Copia	Respond to of 150070

IGNE @ .085 looking good for those LT holders. check out : significant developments rd.yahoo.com*http://yahoo.marketguide.com/mgi/signdevt.asp?rt=signdevt&rn=44395 also it is missing this: On July 6, 2000, a U.S. FDA ruling, which was effective August 8, 2000, allowed Igene to market AstaXin(R) for fish feeds and fish produced in or sent to the United States. As a result of this U.S. FDA ruling, and approvals in 1999 from the Canadian equivalent agency, Igene began to market AstaXin(R) in the United States and Canada in July 2000. In July 2000, Igene also obtained market clearance from the U.S. FDA to sell AstaXin(R) as a human nutritional supplement in the United States. not a buy rec. DD all purchases.